Research Communications of the 24th ECVIM-CA Congress

192 puppies from 58 litters living in a breeding kennel were followed between 4 and 9 weeks of age. Each puppy was treated with fenbendazole (Panacur â , MSD, France, 50 mg/kg, per os, q 24 h) for 3 consecutive days at 2, 4, 6 and 8 weeks of age. For each puppy, fecal consistency was evaluated using a 13-point scale. Excretion of enteropathogens was evaluated by qPCR for canine parvovirus type 2 (CPV2), qRT-PCR for canine coronavirus (CCV), coproantigens quantification for Giardia (ProSpecT-Giardia, Remel), and McMaster flotation technique for any eggs and oocysts. A generalized linear mixed model (proc GLIMMIX) with Giardia infection as a binary outcome was used to assess the following effects: breed size, age, and CPV2, CCV and Isospora ohioensis infections. A linear mixed model (proc MIXED) with fecal score as outcome was used to determine the following effects: breed size, age, and Giardia, CPV2, CCV and I. ohioensis infections.